Imagine a future where the UK leads the way in making life-saving medicines that are not only innovative but also environmentally sustainable. With the right investment, that future can be a reality.
The speed of development and success of the Oxford Astra-Zeneca COVID-19 vaccine highlighted the expertise and infrastructure that makes the UK a leader in biotech. But could we take it one step further and become a global powerhouse in sustainable medicines manufacturing?
Manufacturing medicines already delivers 45% of economic activity within the UK life sciences sector, generating £35.1 billion of turnover in the UK in 2021 and exports of over $25 billion in 2020.